Outcome of Subclassification of Indeterminate (Thy-3) Thyroid Cytology into Thy-3a and Thy-3f

被引:18
|
作者
Brophy, Catherine [1 ]
Mehanna, Rania [1 ]
McCarthy, Julie [3 ]
Tuthill, Antoinette [4 ]
Murphy, Matthew S. [2 ]
Sheahan, Patrick [1 ]
机构
[1] South Infirm Victoria Univ Hosp, Dept Otolaryngol Head & Neck Surg, Cork, Ireland
[2] South Infirm Victoria Univ Hosp, Dept Endocrinol, Cork, Ireland
[3] Cork Univ Hosp, Dept Cytopathol, Cork, Ireland
[4] Cork Univ Hosp, Dept Endocrinol, Cork, Ireland
关键词
Thyroid; Cytology; Thy-3; Thy; Follicular lesion of uncertain significance; Atypia of uncertain significance;
D O I
10.1159/000441221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The British Thy system is a widely used classification system for reporting thyroid fine-needle aspiration (FNA) cytology. The Royal College of Pathologists in 2009 recommended the subdivision of the Thy-3 (indeterminate) category into Thy-3a (atypia) and Thy-3f (follicular neoplasm). Our objective was to examine the malignancy rates of Thy-3a and Thy-3f cases at our institution and to investigate whether the risk of malignancy in Thy-3a cases is reduced by FNA on a different occasion showing benign cytology. Methods: This is a retrospective study of 748 thyroid nodules undergoing 1,032 FNAs, with indeterminate (Thy-3) cytology subdivided into Thy-3a and Thy-3f. Cases were correlated with final histology in surgical cases. Incidental carcinomas occurring outside the biopsied nodule were discounted. Results: A total of 109 nodules had a final cytological diagnosis of Thy-3a, of which 67 underwent surgery, with an incidence of malignancy of 13.4% (9/67); 90 nodules had a final cytological diagnosis of Thy-3f, of which 84 underwent surgery, with an incidence of malignancy of 17.9% (15/84). The difference in malignancy rates was not significant (p = 0.51). The incidence of malignancy in nodules with benign and Thy-3a cytology on separate occasions was not significantly different from cases with a single Thy-3a cytology. Conclusions: Thyroid nodules with Thy-3a cytology have a slightly lower risk of malignancy than Thy-3f cases. However, the difference is not significant and does not appear to be reduced by FNA on a separate occasion showing benign cytology. Management decisions for patients with Thy-3a cytology should be taken carefully to avoid missing cancers. (C) 2015 European Thyroid Association Published by S. Karger AG, Basel
引用
收藏
页码:246 / 251
页数:6
相关论文
共 19 条
  • [1] Thy3 cytology: what to do next?
    Lakhani, Raj
    Rourke, Thomas
    Jefferis, Anthony
    Perry, Louise
    Ghiacy, Sabour
    Wood, Stephen
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (03) : 225 - 228
  • [2] Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
    Gaunt, A.
    Moore, A. R.
    Huvenne, C.
    Dhami, A.
    Eades, M.
    Balasubramanian, S. P.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (12) : 5905 - 5911
  • [3] Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
    A. Gaunt
    A. R. Moore
    C. Huvenne
    A. Dhami
    M. Eades
    S. P. Balasubramanian
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 5905 - 5911
  • [4] Indeterminate thyroid nodules (Thy3): malignancy rate and characteristics in a study of 118 patients
    Dimitriadis, P. A.
    Moinie, A.
    Michaels, J.
    Bance, R.
    Vijendren, A.
    Mochloulis, G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2023, 105 (06) : 568 - 571
  • [5] Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports
    Trimboli, Pierpaolo
    Bongiovanni, Massimo
    Rossi, Fabio
    Guidobaldi, Leo
    Crescenzi, Anna
    Ceriani, Luca
    Nigri, Giuseppe
    Valabrega, Stefano
    Romanelli, Francesco
    Giovanella, Luca
    ENDOCRINE, 2015, 49 (01) : 191 - 195
  • [6] Thy3a nodules with cytological atypia: True indeterminate or papillary thyroid carcinoma waiting for a full diagnosis?
    Piana, Simonetta
    Bisagni, Alessandra
    Frasoldati, Andrea
    CYTOPATHOLOGY, 2021, 32 (03) : 383 - 384
  • [7] Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules
    Sciacchitano, Salvatore
    Lavra, Luca
    Ulivieri, Alessandra
    Magi, Fiorenza
    Porcelli, Tommaso
    Amendola, Stefano
    De Francesco, Gian Paolo
    Bellotti, Carlo
    Trovato, Maria Concetta
    Salehi, Leila B.
    Bartolazzi, Armando
    ENDOCRINE, 2016, 54 (01) : 139 - 147
  • [8] What is Thy3a? A study of 336 Thy3a (AUS/FLUS) thyroid FNAs with histology compares UK RCPath with other reporting systems and shows how Thy3a subclassification can improve risk stratification and help address overuse of this category
    van Der Horst, Cynthia
    Wright, Sylvia
    Young, David
    Tailor, Hitesh
    Clark, Louise
    CYTOPATHOLOGY, 2021, 32 (01) : 29 - 36
  • [9] Prevalence of thyroid carcinoma in nodules with thy 3 cytology: the role of preoperative ultrasonography and strain elastography
    Pikis, Giorgos
    Kandaraki, Eleni
    Lamnisos, Demetris
    Abbara, Sereen
    Kyriakou, Katerina
    Economides, Aliki
    Economides, Panayiotis A.
    THYROID RESEARCH, 2021, 14 (01)
  • [10] Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?
    Calo, Pietro Giorgio
    Medas, Fabio
    Cruz, Rosa Santa
    Podda, Francesco
    Erdas, Enrico
    Pisano, Giuseppe
    Nicolosi, Angelo
    BMC SURGERY, 2014, 14